Overview
Dr. Harsimran Singh grew up in Lancaster, Pennsylvania, earning his undergraduate education in Molecular Biology from Princeton University. He traveled abroad to complete a Masters in Health Care Policy at the London School of Hygiene & Tropical Medicine. He received his medical degree from Yale University School of Medicine. He completed his internship and residency training in Internal Medicine at University of California, San Francisco. He then returned back east to complete his fellowship training and board certification in both Cardiovascular Diseases and Interventional Cardiology from Columbia University – New York Presbyterian Hospital. Finally, he obtained specialized training in Adult Congenital Heart Disease and Structural Interventional Cardiology in Canada at Toronto General Hospital & The Hospital for Sick Children. He has now joined the full-time faculty at Weill Cornell Medical College – New York Presbyterian Hospital as a specialist in Adult Congenital Heart Disease and Interventional Cardiology.
As an interventional cardiologist, Dr. Singh performs percutaneous interventions for coronary artery and valvular disease from both a femoral and radial approach. He has considerable clinical experience in performing percutaneous interventions in adults with congenital and structural heart defects. He has an active clinical cardiology practice that includes patients with both acquired and congenital cardiac conditions. Dr. Singh also speaks Hindi, Punjabi, and Spanish.
Highlights
- 1Pulmonary circulation · 2024
- 2
- 3
Publications
Funding
Active
1 grant- Co-IR01HL166836-01A1The HOPE (Heart Outcomes in Pregnancy: Expectations) for Mom and Baby StudyNational Heart, Lung, and Blood Institute · 2024–2028 · via University of Missouri· 2 renewals
Completed grants (1)
- Co-IRD-2020C2-20347Utilizing PCORnet to support transition from pediatric to adult centered care and reduce gaps in recommended care in patients with congenital heart disease.Patient-Centered Outcomes Research Institute · 2021–2024 · via Louisiana Public Health Institute
Clinical research
Completed & closed trials (4)
- PINCT05185232Utilizing PCORnet to Support Transition From Pediatric to Adult Centered Care and Reduce Gaps in Recommended Care in Patients With Congenital Heart DiseasePatient-Centered Outcomes Research Institute · CLOSED TO ACCRUAL (as of 2023)Congenital Heart Disease; Comorbidities and Coexisting Conditions
- PIPre-procedural ANxiety In Congenital Heart Disease (PANIC)Spectrum Health · IRB STUDY CLOSURE (as of 2022)
- PINCT04339699STITCH - Prospective Multi Center Comparative Parallel Concurrent Study of the NobleStitch EL Compared to FDA Approved Amplatzer Occluder Device for Closure of Patent Foramen Ovale to Prevent Recurrent Ischemic StrokeNA · Nobles Medical Technologies II, Inc. · IRB STUDY CLOSURE (as of 2022)Foramen Ovale, Patent; Stroke, Ischemic
- PICOVID-19 in Adults with Congenital Heart DiseaseUniversity of California, Los Angeles · CLOSED TO ACCRUAL (as of 2021)
News mentions
External relationships
Advisory/Scientific Board Member
McGraw-Hill Education
Other
Abbott Cardiovascular Systems, Inc.